Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.
An interdisciplinary team of researchers from the University of Texas Medical Branch, and Winship Cancer Institute of Emory University have identified small molecules that can represent a new class of anticancer drugs with ...
(HealthDay News) —Besides the danger and worry from the disease itself, many Americans battling cancer are faced with high bills for medical care, two new reports show.
Delays between a patient presenting with symptoms of colorectal cancer to their GP and receiving treatment may have no impact on survival rates, according to a study by academics at the University of Aberdeen.
Western-led research has discovered that timing, in combination with aggression, are possible keys to long-term survival for patients with limited metastatic lung cancer.